References
- 1. Tasic V, Lozanovski VJ, Danilovski D, Laban N, Pop-Jordanova N, Polenakovic M, Gucev ZS. Rare diseases with renal involvement in the Republic of Macedonia. Prilozi. 2011; 32: 55-67.
- 2. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA. 2009; 106: 19096-101.
- 3. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, et al. SRNS Study Group, Hildebrandt F. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015; 26: 1279-89.
- 4. Lovric S, Ashraf S, Tan W, Hildebrandt F. Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant. 2015 Oct 27. pii: gfv355. [Epub ahead of print]
- 5. Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, et al. PodoNet Consortium. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. 2015; 10: 592-600.
- 6. Ashraf S, Gee HY, Woerner S, Xie LX, Vega- Warner V, Lovric S, Fang H, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013; 123: 5179-89.
- 7. Horling K, Schlegel G, Schulz S, Vierk R, Ullrich K, Santer R, Rune GM. Hippocampal synaptic connectivity in phenylketonuria. Hum Mol Genet. 2015; 24: 1007-18.
- 8. Tournev I. The Meryon Lecture at the 18th Annual Meeting of the Meryon Society Wolfson College, Oxford, UK, 12th September 2014: Neuromuscular disorders in Roma (Gypsies) - collaborative studies, epidemiology, community-based carrier testing program and social activities. Neuromuscul Disord. 2015 Oct 22. pii: S0960-8966(15)00744-0.
- 9. Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VE, Blumhorst C, Darling T, Tosi LL, et al. Clinical delineation and natural history of the PIK3CArelated overgrowth spectrum. Am J Med Genet A. 2014; 164A: 1713-33.
- 10. Gucev ZS, Tasic V, Jancevska A, Konstantinova MK, Pop-Jordanova N, Trajkovski Z, Biesecker LG. Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder. Am J Med Genet A. 2008; 146A: 2688-90.
- 11. Lindhurst MJ, Parker VE, Payne F, Sapp JC, Rudge S, Harris J, Witkowski AM, et al. Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet. 2012; 44: 928-33.
- 12. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011; 365: 410-21.
- 13. Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, Pronicka E, et al. Autosomal- Recessive Mutations in SLC34A1 Encoding Sodium- Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia. J Am Soc Nephrol. 2015 Jun 5. pii: ASN.2014101025. [Epub ahead of print]
- 14. Baltsavias G, Khan N, Filipce V, Valavanis A. Selective and superselective angiography of pediatric moyamoya disease angioarchitecture in the posterior circulation. Interv Neuroradiol. 2014; 20: 403-12.
- 15. Baltsavias G, Valavanis A, Filipce V, Khan N. Selective and superselective angiography of pediatric moyamoya disease angioarchitecture: the anterior circulation. Interv Neuroradiol. 2014; 20: 391-402.